Hruban RH - Search Results

1

Prioritization of driver mutations in pancreatic cancer using cancer-specific high-throughput annotation of somatic mutations (CHASM).

Carter H, Samayoa J, Hruban RH, Karchin R. Carter H, et al. Among authors: hruban rh. Cancer Biol Ther. 2010 Sep 15;10(6):582-7. doi: 10.4161/cbt.10.6.12537. Epub 2010 Oct 1. Cancer Biol Ther. 2010. PMID: 20581473 Free PMC article.

2

Familial pancreatic cancer and the genetics of pancreatic cancer.

Lumadue JA, Griffin CA, Osman M, Hruban RH. Lumadue JA, et al. Among authors: hruban rh. Surg Clin North Am. 1995 Oct;75(5):845-55. doi: 10.1016/s0039-6109(16)46731-9. Surg Clin North Am. 1995. PMID: 7660249 Free article. Review.

3

Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma.

Caldas C, Hahn SA, da Costa LT, Redston MS, Schutte M, Seymour AB, Weinstein CL, Hruban RH, Yeo CJ, Kern SE. Caldas C, et al. Among authors: hruban rh. Nat Genet. 1994 Sep;8(1):27-32. doi: 10.1038/ng0994-27. Nat Genet. 1994. PMID: 7726912

4

p53 mutations in pancreatic carcinoma and evidence of common involvement of homocopolymer tracts in DNA microdeletions.

Redston MS, Caldas C, Seymour AB, Hruban RH, da Costa L, Yeo CJ, Kern SE. Redston MS, et al. Among authors: hruban rh. Cancer Res. 1994 Jun 1;54(11):3025-33. Cancer Res. 1994. PMID: 8187092

5

Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas.

Goggins M, Schutte M, Lu J, Moskaluk CA, Weinstein CL, Petersen GM, Yeo CJ, Jackson CE, Lynch HT, Hruban RH, Kern SE. Goggins M, et al. Among authors: hruban rh. Cancer Res. 1996 Dec 1;56(23):5360-4. Cancer Res. 1996. PMID: 8968085

6

Tumor-suppressive pathways in pancreatic carcinoma.

Rozenblum E, Schutte M, Goggins M, Hahn SA, Panzer S, Zahurak M, Goodman SN, Sohn TA, Hruban RH, Yeo CJ, Kern SE. Rozenblum E, et al. Among authors: hruban rh. Cancer Res. 1997 May 1;57(9):1731-4. Cancer Res. 1997. PMID: 9135016

7

p16 and K-ras gene mutations in the intraductal precursors of human pancreatic adenocarcinoma.

Moskaluk CA, Hruban RH, Kern SE. Moskaluk CA, et al. Among authors: hruban rh. Cancer Res. 1997 Jun 1;57(11):2140-3. Cancer Res. 1997. PMID: 9187111

8

Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas.

Schutte M, Hruban RH, Geradts J, Maynard R, Hilgers W, Rabindran SK, Moskaluk CA, Hahn SA, Schwarte-Waldhoff I, Schmiegel W, Baylin SB, Kern SE, Herman JG. Schutte M, et al. Among authors: hruban rh. Cancer Res. 1997 Aug 1;57(15):3126-30. Cancer Res. 1997. PMID: 9242437

9

K-ras mutations in the duodenal fluid of patients with pancreatic carcinoma.

Wilentz RE, Chung CH, Sturm PD, Musler A, Sohn TA, Offerhaus GJ, Yeo CJ, Hruban RH, Slebos RJ. Wilentz RE, et al. Among authors: hruban rh. Cancer. 1998 Jan 1;82(1):96-103. doi: 10.1002/(sici)1097-0142(19980101)82:1<96::aid-cncr11>3.0.co;2-8. Cancer. 1998. PMID: 9428484

10

Alterations in pancreatic, biliary, and breast carcinomas support MKK4 as a genetically targeted tumor suppressor gene.

Su GH, Hilgers W, Shekher MC, Tang DJ, Yeo CJ, Hruban RH, Kern SE. Su GH, et al. Among authors: hruban rh. Cancer Res. 1998 Jun 1;58(11):2339-42. Cancer Res. 1998. PMID: 9622070

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,072 results

Search Page

Filters